In one study, it was reported that the weight gain is prominent in normal-weight girls under GnRH analogue treatment, while there is no significant weight gain in girls who already have obesity in the beginning of the therapy. This evidence concerns the gene GNRH1 and obesity due to melanocortin 4 receptor deficiency.